NMD Pharma
Management — NMD Pharma
NMD Pharma - Inkef capital
NMD Pharma A/S | LinkedIn
ALS Therapy Developer NMD Pharma Obtains $47 Million in New Financing
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma treats first patient with the firm's most promising drug candidate
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
NMD Pharma Receives Approval to Start a combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
Thomas Holm Pedersen – CEO – NMD Pharma | LinkedIn
NMD Pharma - Inkef capital
NMD Pharma - Inkef capital
NMD Pharma - PIR International
Foundations invest DKK 280 million in biomedical company
NMD Pharma - Inkef capital
Prominent Canadian researcher in Denmark: Why I left a top job in California
NMD Pharma
NMD Pharma raises €38M (~USD 47 Million) SERIES A Financing to Advance Treatments of Neuromuscular Disorders
NMD Pharma treats first patient with the firm's most promising drug candidate
NMD Pharma Initiates a Combined Phase I/IIa Clinical Trial of NMD670 for the Treatment of Symptoms of Myasthenia Gravis
NMD Pharma A/S | LinkedIn
Rare Neuromuscular Disease Company NMD Pharma Raises USD 3 Million in Seed Financing Round - Lundbeckfonden
NMD Pharma is Strengthening Muscles in Neuromuscular Disorders
Biopeople Newsletter January 2020 - Biopeople
NMD Pharma - PIR International
